Online Trial of Meditation and Behavior

Meditation Clinical Trial

Official title:

Identifying Neural Correlates of Altruism

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04632875
• Other study ID #: 2010-180-2
• Status: Completed
• Phase: N/A
• Start date: December 4, 2020
• Est. completion date: June 10, 2021

Study information

• Verified date: November 2020
• Source: Georgetown University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study investigates how different types of meditation may affect behaviors and emotions. The study is conducted entirely online and involves listening to 4-weeks of a guided meditation training. The meditation involves either Loving-Kindness or Relaxation techniques. The purpose of the study is to assess changes in behaviors and emotions using standard questionnaires, reports of real-world behavior, and online behavioral tasks. The overarching goal is to help clarify how mind-body practices may improve some aspects of well-being.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 75
• Est. completion date: June 10, 2021
• Est. primary completion date: June 10, 2021
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 55 Years

Eligibility

Inclusion Criteria:

• Is a medically healthy individual

• Lives in the United States

• Has reliable internet access and the ability to join a Zoom video chat

Exclusion Criteria:

• Has experience with meditation or other mind-body practices

• Has a neurological disease

• Has a current psychiatric disorder

• Is on medication that affects the central nervous system (e.g. psychotropic drugs)

• Has recurrent or chronic pain

• Is pregnant or planning to become pregnant

Related Conditions & MeSH terms

• Meditation

Intervention

Behavioral:
• Loving-Kindness Meditation
Approximately 15-minute sessions are administered 6 days per week
• Relaxation Meditation
Approximately 15-minute sessions are administered 6 days per week

Locations

Country	Name	City	State
United States	Georgetown University	Washington	District of Columbia

Sponsors (1)

Lead Sponsor	Collaborator
Georgetown University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Social functioning	Participants will complete a questionnaire about their real-world social behaviors. An aggregate score will be computed; higher scores will indicate better social functioning.	4-5 weeks
Primary	Affective responses	Participants will perform a wall-sit test and responses will be measured using a 0-100 Visual Analog Scale of intensity.	4-5 weeks
Secondary	Psychological well-being related to COVID-19	Participants will complete a questionnaire related to the psychological impact of COVID-19 social distancing. Higher scores will indicate worse psychological impact of COVID-19.	4-5 weeks